Long-term patterns of subjective wellbeing in schizophrenia: Cluster, predictors of cluster affiliation, and their relation to recovery criteria in 2842 patients followed over 3 years

Schizophrenia Research

Volumn 107, Issue 2-3, 2009, Pages 165-172

  Lambert, Martin ^a   Schimmelmann, Benno G ^a,b   Schacht, Alexander ^c   Karow, Anne ^a   Wagner, Thomas ^c   Wehmeier, Peter M ^c   Huber, Christian G ^a   Hundemer, Hans Peter ^c   Dittmann, Ralf W ^c,d   Naber, Dieter ^a  

^a Centre for Psychosocial Medicine   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

^c LILLY DEUTSCHLAND GMBH   (Germany)

^d UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Cluster analysis; Quality of life; Recovery; Schizophrenia; Subjective wellbeing

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; NEUROLEPTIC AGENT;

ADULT; ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; CLUSTER ANALYSIS; CONVALESCENCE; DISEASE COURSE; DISEASE SEVERITY; EXTRAPYRAMIDAL SYMPTOM; FEMALE; FOLLOW UP; GERMANY; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; OBSERVATIONAL STUDY; PATIENT COMPLIANCE; POSITIVE AND NEGATIVE SYNDROME SCALE; PREDICTION; PRIORITY JOURNAL; PSYCHOLOGICAL RATING SCALE; QUALITY OF LIFE; REMISSION; SCHIZOPHRENIA; SCORING SYSTEM; SUBSTANCE ABUSE; SYMPTOM; TARDIVE DYSKINESIA; WELLBEING;

ADULT; CLUSTER ANALYSIS; FEMALE; GERMANY; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PROGNOSIS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SOCIAL ADJUSTMENT;

EID: 58249093242     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2008.08.035     Document Type: Article

References (29)

1. Andreasen N.C., Carpenter Jr. W.T., Kane J.M., Lasser R.A., Marder S.R., and Weinberger D.R. Remission in schizophrenia: proposed criteria and rationale for consensus. Am. J. Psychiatry 162 (2005) 441-449
2. APA. Diagnostic Criteria from DSM-IV (1994), American Psychiatric Publishing, Washington, DC
3. Bellack A.S. Scientific and consumer models of recovery in schizophrenia: concordance, contrasts, and implications. Schizophr. Bull. 32 (2006) 432-442
4. Drake R.E., McHugo G.J., Xie H., Fox M., Packard J., and Helmstetter B. Ten-year recovery outcomes for clients with co-occurring schizophrenia and substance use disorders. Schizophr. Bull. 32 (2006) 464-473
5. Flyckt L., Mattsson M., Edman G., Carlsson R., and Cullberg J. Predicting 5-year outcome in first-episode psychosis: construction of a prognostic rating scale. J. Clin. Psychiatry 67 (2006) 916-924
6. Guy W. ECDEU Assessment Manual for Psychopharmacology, revised. US Dept Health, Education, and Welfare Publication (ADM) 76-338 (1976), National Institute of Mental Health, Rockville Md 218-222
7. Haro J.M., and Salvador-Carulla L. The SOHO (Schizophrenia Outpatient Health Outcome) study: implications for the treatment of schizophrenia. CNS Drugs 20 (2006) 293-301
8. Haro J.M., Kamath S.A., Ochoa S., Novick D., Rele K., Fargas A., Rodriguez M.J., Rele R., Orta J., Kharbeng A., Araya S., Gervin M., Alonso J., Mavreas V., Lavrentzou E., Liontos N., Gregor K., Jones P.B., and SOHO Study Group. The Clinical Global Impression-Schizophrenia scale: a simple instrument to measure the diversity of symptoms present in schizophrenia. Acta. Psychiatr. Scand. 107 suppl. 416 (2003) 16-23
9. Harrison G., Hopper K., Craig T., Laska E., Siegel C., Wanderling J., Dube K.C., Ganev K., Giel R., an der Heiden W., Holmberg S.K., Janca A., Lee P.W., Leon C.A., Malhotra S., Marsella A.J., Nakane Y., Sartorius N., Shen Y., Skoda C., Thara R., Tsirkin S.J., Varma V.K., Walsh D., and Wiersma D. Recovery from psychotic illness: a 15- and 25-year international follow-up study. Br. J. Psychiatry 178 (2001) 506-517
10. Jobe T.H., and Harrow M. Long-term outcome of patients with schizophrenia: a review. Can. J. Psychiatry 50 (2005) 892-900
11. Kane J.M., Leucht S., Carpenter D., and Docherty J.P. Expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary. J. Clin. Psychiatry 64 Suppl 12 (2003) 5-19
12. Karow A., Czekalla J., Dittmann R.W., Schacht A., Wagner T., Lambert M., Schimmelmann B.G., and Naber D. Association of subjective well-being, symptoms, and side effects with compliance after 12 months of treatment in schizophrenia. J. Clin. Psychiatry 68 (2007) 75-80
13. Karow A., Moritz S., Lambert M., Schoder S., and Krausz M. PANSS syndromes and quality of life in schizophrenia. Psychopathology 38 (2005) 320-326
14. Lambert M., and Naber D. Current issues in schizophrenia: overview of patient acceptability, functioning capacity and quality of life. CNS Drugs 18 Suppl 2 (2004) 5-17 discussion 41-3
15. Lambert M., Naber D., Eich F.X., Schacht M., Linden M., and Schimmelmann B.G. Remission of severely impaired subjective wellbeing in 727 patients with schizophrenia treated with amisulpride. Acta Psychiatr. Scand. 115 (2007) 106-113
16. Lambert M., Schimmelmann B.G., Karow A., and Naber D. Subjective wellbeing and initial dysphoric reaction under antipsychotic drugs - concepts, measurement and clinical relevance. Pharmacopsychiatry 36 Suppl 3 (2003) 181-190
17. Lambert M., Schimmelmann B.G., Naber D., Schacht A., Karow A., Wagner T., and Czekalla J. Prediction of remission as a combination of symptomatic and functional remission and adequate subjective well-being in 2960 patients with schizophrenia. J. Clin. Psychiatry 67 (2006) 1690-1697
18. Leucht S., Busch R., Kissling W., and Kane J.M. Early prediction of antipsychotic nonresponse among patients with schizophrenia. J. Clin. Psychiatry 68 (2007) 352-360
19. Liberman R.P., and Kopelowicz A. Recovery from schizophrenia: a concept in search of research. Psychiatr. Serv. 56 (2005) 735-742
20. Liberman R.P., Kopelowicz A., Ventura J., and Gutkind D. Operational criteria and factors related to recovery from schizophrenia. Int. Rev. Psychiatry 14 (2002) 256-272
21. Marwaha S., and Johnson S. Schizophrenia and employment - a review. Soc. Psychiatry Psychiatr. Epidemiol. 39 (2004) 337-349
22. Naber D., Moritz S., Lambert M., Pajonk F.G., Holzbach R., Mass R., and Andresen B. Improvement of schizophrenic patients' subjective well-being under atypical antipsychotic drugs. Schizophr. Res. 50 (2001) 79-88
23. President's New Freedom Commission on Mental Health. Achieving the Promise: Transforming Mental Health Care in America. 2003; http://www.mentalhealthcommission.gov/index.html
24. Prieto L., Novick D., Sacristan J.A., Edgell E.T., and Alonso J. A Rasch model analysis to test the cross-cultural validity of the EuroQoL-5D in the Schizophrenia Outpatient Health Outcomes Study. Acta Psychiatr. Scand. Suppl. (2003) 24-29
25. Resnick S.G., Fontana A., Lehman A.F., and Rosenheck R.A. An empirical conceptualization of the recovery orientation. Schizophr. Res. 75 (2005) 119-128
26. Robinson D.G., Woerner M.G., McMeniman M., Mendelowitz A., and Bilder R.M. Symptomatic and functional recovery from a first episode of schizophrenia or schizoaffective disorder. Am. J. Psychiatry 161 (2004) 473-479
27. Siegel S.J., Irani F., Brensinger C.M., Kohler C.G., Bilker W.B., Ragland J.D., Kanes S.J., Gur R.C., and Gur R.E. Prognostic variables at intake and long-term level of function in schizophrenia. Am. J. Psychiatry 163 (2006) 433-441
28. Wehmeier P.M., Kluge M., Schacht A., Helsberg K., and Schreiber W. Correlation of physician and patient rated quality of life during antipsychotic treatment in outpatients with schizophrenia. Schizophr. Res. 91 (2007) 178-186
29. Wehmeier P.M., Kluge M., Schneider E., Schacht A., Wagner T., and Schreiber W. Quality of life and subjective well-being during treatment with antipsychotics in out-patients with schizophrenia. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 31 (2007) 703-712